3o2w
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Crystal structure of the 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe Fab in complex with a 39A11 transition state analog== | ==Crystal structure of the 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe Fab in complex with a 39A11 transition state analog== | ||
<StructureSection load='3o2w' size='340' side='right' caption='[[3o2w]], [[Resolution|resolution]] 2.55Å' scene=''> | <StructureSection load='3o2w' size='340' side='right' caption='[[3o2w]], [[Resolution|resolution]] 2.55Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3o2w]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3o2w]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O2W OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3O2W FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=FLC:CITRATE+ANION'>FLC</scene>, <scene name='pdbligand=O2W:METHYL+({[(3AR,4R,7R,7AR)-2-(4-AMINOPHENYL)-1,3-DIOXOOCTAHYDRO-4H-4,7-ETHANOISOINDOL-4-YL]CARBAMOYL}OXY)ACETATE'>O2W</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TRS:2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL'>TRS</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=FLC:CITRATE+ANION'>FLC</scene>, <scene name='pdbligand=O2W:METHYL+({[(3AR,4R,7R,7AR)-2-(4-AMINOPHENYL)-1,3-DIOXOOCTAHYDRO-4H-4,7-ETHANOISOINDOL-4-YL]CARBAMOYL}OXY)ACETATE'>O2W</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TRS:2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL'>TRS</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3o2v|3o2v]], [[1c1e|1c1e]], [[1a4k|1a4k]], [[2o5x|2o5x]], [[2o5y|2o5y]], [[2o5z|2o5z]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3o2v|3o2v]], [[1c1e|1c1e]], [[1a4k|1a4k]], [[2o5x|2o5x]], [[2o5y|2o5y]], [[2o5z|2o5z]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3o2w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3o2w OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3o2w RCSB], [http://www.ebi.ac.uk/pdbsum/3o2w PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3o2w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3o2w OCA], [http://pdbe.org/3o2w PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3o2w RCSB], [http://www.ebi.ac.uk/pdbsum/3o2w PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3o2w ProSAT]</span></td></tr> |
</table> | </table> | ||
==See Also== | ==See Also== | ||
| - | *[[ | + | *[[3D structures of antibody|3D structures of antibody]] |
| - | *[[ | + | *[[3D structures of monoclonal antibody|3D structures of monoclonal antibody]] |
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Lk3 transgenic mice]] |
| - | + | ||
[[Category: Verdino, P]] | [[Category: Verdino, P]] | ||
[[Category: Wilson, I A]] | [[Category: Wilson, I A]] | ||
[[Category: Igg antibody fab]] | [[Category: Igg antibody fab]] | ||
[[Category: Immune system]] | [[Category: Immune system]] | ||
Revision as of 04:03, 10 December 2016
Crystal structure of the 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe Fab in complex with a 39A11 transition state analog
| |||||||||||
